Europe Optical Imaging Market: By Technology (Photoacoustic Imaging, Optical Coherence Tomography (OCT), Hyperspectral Imaging, Near Infrared Spectroscopy and Others), By Application (Dermatology, Ophthalmology, Dentistry, Neurology, Cardiology, Oncology and Others), By End User (Hospitals, Research Laboratories, Medical Imaging Centres and Others) and Country Forecast 2020-2031

Europe Optical Imaging Market size was valued at US$ X million in 2024 and is expected to reach US$ X million by 2031, growing at a significant CAGR of X% from 2025-2031. The Europe market provides a detailed overview and that can be segmented by technology, by application, and by end user. By technology, the Europe optical imaging market has been segmented into Photoacoustic Imaging, Optical Coherence Tomography (OCT), Hyperspectral Imaging, Near Infrared Spectroscopy, and Others. The Optical Coherence Tomography (OCT) segment is likely to be the largest and fastest-growing segment in terms of technology due to various use case in broad range of research & clinical applications. OCT enables real time data regarding high-resolution cross-sectional imaging of tissue structures. OCT is a three-dimensional non-invasive technology based on advanced photonics and fiber optics technologies. Based on application, the Europe optical imaging market is segmented into Dermatology, Ophthalmology, Dentistry, Neurology, Cardiology, Oncology, and Others. Among these, the Dermatology segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on end user, the Europe optical imaging market is segmented into Hospitals, Research Laboratories, Medical Imaging Centres and Others. The hospital segment accounts for the largest share in 2021 and is expected to maintain the growth in the forecasted years. Optical imaging is a rapidly evolving and emerging medical advanced imaging technology that assesses the optical properties of various body tissues by utilising the light spectrum. This emerging technology has enormous potential for disease diagnostic and prevention, as well as it helps in life science and clinical research.  

Key Development

• In April 2021, Abbott announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe. This first-of-its-kind imaging software merges optical coherence tomography (OCT).